Literature DB >> 8713099

Salt-sensitive hypertension in bradykinin B2 receptor knockout mice.

M E Alfie1, X P Yang, F Hess, O A Carretero.   

Abstract

The kallikrein-kinin system regulates water and sodium excretion and thus plays a role in blood pressure (BP) homeostasis. We tested the hypothesis that mice lacking the gene encoding for the bradykinin B2 receptor (B2-KO) have a greater hypertensive response to chronic high Na+ intake (salt sensitivity) compared to controls. We also obtained dose-response curves for different vasoactive substances in both groups. The hypertensive effect of high Na+ intake was almost doubled in B2-KO mice compared to controls. A high-Na+ diet increased heart and kidney weight in B2-KO, but not in controls, suggesting an increased afterload in B2-KO mice. The BP response to bradykinin was completely abolished in B2-KO, but that to acetylcholine was conserved. The hypertensive response to angiotensin II was not exaggerated in B2-KO mice. This study describes a new salt-sensitive animal model and suggests that in mice kinins play a role in preventing salt-sensitive hypertension.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8713099     DOI: 10.1006/bbrc.1996.1076

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Salt-sensitive hypertension: if only it were as simple as rocket science.

Authors:  Timothy L Reudelhuber
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  Comparative antagonist pharmacology at the native mouse bradykinin B2 receptor: radioligand binding and smooth muscle contractility studies.

Authors:  S Meini; P Cucchi; F Bellucci; C Catalani; S Giuliani; P Santicioli; C A Maggi
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

Review 3.  Kinin receptors.

Authors:  F Marceau; D R Bachvarov
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

Review 4.  Cardioprotective mechanisms of ACE inhibition. The angiotensin II-nitric oxide balance.

Authors:  G H Gibbons
Journal:  Drugs       Date:  1997       Impact factor: 9.546

5.  Mesangial AT1/B2 receptor heterodimers contribute to angiotensin II hyperresponsiveness in experimental hypertension.

Authors:  Said AbdAlla; Ahmed Abdel-Baset; Heinz Lother; Adel el Massiery; Ursula Quitterer
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

6.  Salt-dependent inhibition of epithelial Na+ channel-mediated sodium reabsorption in the aldosterone-sensitive distal nephron by bradykinin.

Authors:  Mykola Mamenko; Oleg Zaika; Peter A Doris; Oleh Pochynyuk
Journal:  Hypertension       Date:  2012-10-01       Impact factor: 10.190

7.  The role of the kallikrein-kinin system genes in the salt sensitivity of blood pressure: the GenSalt Study.

Authors:  Dongfeng Gu; Qi Zhao; Tanika N Kelly; James E Hixson; Dabeeru C Rao; Jie Cao; Jing Chen; Jianxin Li; Jichun Chen; Xu Ji; Dongsheng Hu; Xushan Wang; De-Pei Liu; Jiang He
Journal:  Am J Epidemiol       Date:  2012-10-01       Impact factor: 4.897

8.  High salt-induced hypertension in B2 knockout mice is corrected by the ETA antagonist, A127722.

Authors:  I Brochu; M Houde; L Desbiens; E Simard; F Gobeil; W Semaan; G Bkaily; P D'Orléans-Juste
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

9.  Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae isolated from UT receptor knockout mice.

Authors:  David J Behm; Stephen M Harrison; Zhaohui Ao; Kristeen Maniscalco; Susan J Pickering; Evelyn V Grau; Tina N Woods; Robert W Coatney; Christopher P A Doe; Robert N Willette; Douglas G Johns; Stephen A Douglas
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

10.  Genetic disruption of gamma-melanocyte-stimulating hormone signaling leads to salt-sensitive hypertension in the mouse.

Authors:  Xi-Ping Ni; David Pearce; Andrew A Butler; Roger D Cone; Michael H Humphreys
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.